|
MSMO1 |
methylsterol monooxygenase 1 |
- Cholesterol biosynthesis
- Cholesterol biosynthesis via lathosterol
|
|
|
|
MSX2 |
msh homeobox 2 |
- Regulation of RUNX2 expression and activity
|
|
- Enlarged parietal foramina/cranium bifidum
- Craniosynostosis, including: Pfeiffer syndrome; Apert syndrome; Crouzon syndrome; Jackson-Weiss syndrome; Beare-Stevenson syndrome; Muenke craniosynostosis; Saethre-Chotzen syndrome; Craniosynostosis Boston type; Antley-Bixler syndrome; Carpenter syndrome; Craniofrontonasal dysplasia; Noonan syndrome; Baller-Gerold syndrome
|
|
MTERF4 |
mitochondrial transcription termination factor 4 |
- rRNA modification in the mitochondrion
|
|
|
|
MYO18A |
myosin XVIIIA |
- Signaling by cytosolic FGFR1 fusion mutants
- Signaling by FGFR1 in disease
- Signaling by FLT3 fusion proteins
- Signaling by FLT3 fusion proteins
|
|
|
|
NARS1 |
asparaginyl-tRNA synthetase 1 |
- Cytosolic tRNA aminoacylation
|
|
|
|
NCAM1 |
neural cell adhesion molecule 1 |
- ECM proteoglycans
- NCAM signaling for neurite out-growth
- NCAM signaling for neurite out-growth
- NCAM1 interactions
- NCAM1 interactions
- Signal transduction by L1
- RAF/MAP kinase cascade
- Interferon gamma signaling
|
|
|
|
NCOR1 |
nuclear receptor corepressor 1 |
- Nuclear signaling by ERBB4
- Nuclear signaling by ERBB4
- PPARA activates gene expression
- PPARA activates gene expression
- NOTCH1 Intracellular Domain Regulates Transcription
- Transcriptional activation of mitochondrial biogenesis
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- HDACs deacetylate histones
- Notch-HLH transcription pathway
- Transcriptional regulation of white adipocyte differentiation
- Transcriptional regulation of white adipocyte differentiation
- Nuclear Receptor transcription pathway
- Regulation of lipid metabolism by PPARalpha
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- Loss of MECP2 binding ability to the NCoR/SMRT complex
- Regulation of MECP2 expression and activity
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- HCMV Early Events
- NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
- Cytoprotection by HMOX1
- Heme signaling
- Heme signaling
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
|
|
|
|
NCOR2 |
nuclear receptor corepressor 2 |
- PPARA activates gene expression
- NOTCH1 Intracellular Domain Regulates Transcription
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- HDACs deacetylate histones
- Notch-HLH transcription pathway
- Transcriptional regulation of white adipocyte differentiation
- Transcriptional regulation of white adipocyte differentiation
- Nuclear Receptor transcription pathway
- SUMOylation of transcription cofactors
- Regulation of lipid metabolism by PPARalpha
- Loss of MECP2 binding ability to the NCoR/SMRT complex
- Regulation of MECP2 expression and activity
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- HCMV Early Events
- NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
- Cytoprotection by HMOX1
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
|
|
|
|
NFYA |
nuclear transcription factor Y subunit alpha |
- PPARA activates gene expression
- Activation of gene expression by SREBF (SREBP)
- Activation of gene expression by SREBF (SREBP)
- ATF4 activates genes in response to endoplasmic reticulum stress
- ATF6 (ATF6-alpha) activates chaperone genes
- ATF6 (ATF6-alpha) activates chaperone genes
- FOXO-mediated transcription of cell death genes
|
|
|
|
NHSL2 |
NHS like 2 |
|
|
|
|
NLGN3 |
neuroligin 3 |
- Neurexins and neuroligins
- Neurexins and neuroligins
|
|
|
|
NLK |
nemo like kinase |
|
|
|
|
NPHP3 |
nephrocystin 3 |
- Trafficking of myristoylated proteins to the cilium
|
|
- Renal-hepatic-pancreatic dysplasia
- Meckel syndrome (MKS); Meckel-Gruber syndrome
- Nephronophthisis-medullary cystic kidney disease, including; Nephronophthisis (NPH) ; Nephronophthisis-like nephropathy 1; Medullary cystic kidney disease 1; Medullary cystic kidney disease 2 (MSKD2)
- Senior-Loken syndrome
|
|
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
- AKT phosphorylates targets in the nucleus
- Nuclear Receptor transcription pathway
- Constitutive Signaling by AKT1 E17K in Cancer
|
|
|
|
NUDT21 |
nudix hydrolase 21 |
- mRNA 3'-end processing
- Processing of Capped Intron-Containing Pre-mRNA
- RNA Polymerase II Transcription Termination
- Processing of Intronless Pre-mRNAs
|
|
|
|
NUMBL |
NUMB like endocytic adaptor protein |
|
|
|
|
NUTM2B |
NUT family member 2B |
|
|
|
|
OAZ1 |
ornithine decarboxylase antizyme 1 |
- Regulation of ornithine decarboxylase (ODC)
- Metabolism of polyamines
|
|
|
|
OPCML |
opioid binding protein/cell adhesion molecule like |
- Post-translational modification: synthesis of GPI-anchored proteins
|
|
|
|
OTX2 |
orthodenticle homeobox 2 |
- Formation of the anterior neural plate
- Formation of the posterior neural plate
|
|
- Anophthalmia and microphthalmia (A/M)
- Septo-optic dysplasia
|